|
KDSR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43639544702978E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11400000335493E-10 |
| Normal-vs-Stage2 |
2.46829999994702E-07 |
| Normal-vs-Stage3 |
1.14320000021984E-07 |
| Normal-vs-Stage4 |
2.5495000000042E-07 |
| Stage1-vs-Stage2 |
5.221800E-01 |
| Stage1-vs-Stage3 |
7.236200E-01 |
| Stage1-vs-Stage4 |
9.679400E-01 |
| Stage2-vs-Stage3 |
4.307800E-01 |
| Stage2-vs-Stage4 |
6.137600E-01 |
| Stage3-vs-Stage4 |
7.778800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.66280372488382E-11 |
| Normal-vs-AfricanAmerican |
1.520420E-02 |
| Normal-vs-Asian |
4.1640000000065E-05 |
| Caucasian-vs-AfricanAmerican |
5.632400E-02 |
| Caucasian-vs-Asian |
3.917600E-01 |
| AfricanAmerican-vs-Asian |
2.514800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4752998822587E-10 |
| Normal-vs-Female |
2.16149986798087E-10 |
| Male-vs-Female |
2.327200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.05409999617834E-08 |
| Normal-vs-Age(41-60Yrs) |
5.70450020553892E-10 |
| Normal-vs-Age(61-80Yrs) |
6.16999995539658E-09 |
| Normal-vs-Age(81-100Yrs) |
1.203980E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.955800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.683400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.361200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.389000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.953400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.580600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.464800E-01 |
| Classical-VS-Follicular |
7.70170000000681E-05 |
| Classical-VS-Other |
1.792040E-01 |
| Classical-VS-Normal |
5.46050005212351E-09 |
| Tall-VS-Follicular |
2.960900E-03 |
| Tall-VS-Other |
9.532400E-02 |
| Tall-VS-Normal |
4.038700E-03 |
| Follicular-VS-Other |
9.914400E-01 |
| Follicular-VS-Normal |
1.96129779084231E-11 |
| Other-VS-Normal |
2.195100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.41350264826201E-11 |
| Normal-vs-N1 |
2.35179999918955E-08 |
| N0-vs-N1 |
6.301800E-01 |
|
|
